SoP
Desconocido
NANORESISTANCE: Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems
THE SCHOOL OF PHARMACY, UNIVERSITY OF LONDON
participó en un
FP7:
NANORESISTANCE introduces for the first time (i) receptor -independent targeting of Epidermal Growth Factor Receptor-kinase activity, (ii) n...
Financiado
Financiado
NANONEUROHOP: Assessment of the hazard and opportunities of using carbon nanotubes as a new nanocarrier for drug d...
THE SCHOOL OF PHARMACY, UNIVERSITY OF LONDON
participó en un
FP7:
"While neurodegenerative disorders and brain cancers increase in the population, current therapies have shown their limits. But thanks to re...
Financiado
Financiado
* No se disponen de datos de la empresa actual.